Pulse Biosciences PLSE
NASDAQ PLSE
$49.83 -0.09 (-0.18%)
At close: Oct 1, 2026 · 4:00 PM EDT

Pulse Biosciences (PLSE) EBIT Margin (2021 - 2026)

Updated

Pulse Biosciences' EBIT Margin came in at -5823.04% for Q2 2026.

Analysis

Pulse Biosciences (PLSE) EBIT Margin (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Pulse Biosciences reported EBIT Margin of -10735.59%; for FY2025, it was -21982.57%.

  • EBIT Margin carries a four-year change of -17538.71 percentage points (FY2021 to FY2025).
  • Going back by year, EBIT Margin was -8293.86% in FY2022 (-3849.99 pp) and -4443.86% in FY2021.
  • The Q2 2026 figure represents the highest quarterly EBIT Margin since Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 13.44%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 33.60%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 18.08%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 25.18%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 21.65%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 29.48%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 13.31%
10 Pulse Biosciences 3.53 Bn 3.53 Bn 161,000.00 -5,823.04%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5,823.04%
Dec 31, 2025 -6,914.02%
Sep 30, 2025 -23,682.56%
Jun 30, 2022 -4,671.33%
Mar 31, 2022 -3,890.32%
Dec 31, 2021 -1,825.83%
Sep 30, 2021 -2,486.59%
API Access

Pulse Biosciences EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=PLSE&period=max&api_key=YOUR_API_KEY